Abstract:The prevalence of diabetes steadily increases worldwide mirroring the prevalence of obesity. Endoplasmic reticulum (ER) stress is activated in diabetes and contributes to β-cell dysfunction and apoptosis through the activation of a terminal unfolded protein response (UPR). Our results uncover a new role for Bax Inhibitor-One (BI-1), a negative regulator of inositol-requiring enzyme 1 (IRE1α) in preserving β-cell health against terminal UPR-induced apoptosis and pyroptosis in the context of supraphysiological loads of insulin production. BI-1- deficient mice experience a decline in endocrine pancreatic function in physiological and pathophysiological conditions, namely obesity induced by high-fat diet (HFD). We observed early-onset diabetes characterized by hyperglycemia, reduced serum insulin levels, β-cell loss, increased pancreatic lipases and pro-inflammatory cytokines, and the progression of metabolic dysfunction. Pancreatic section analysis revealed that BI-1 deletion overburdens unfolded proinsulin in the ER of β-cells, confirmed by ultrastructural signs of ER stress with overwhelmed IRE1α endoribonuclease (RNase) activity in freshly isolated islets. ER stress led to β-cell dysfunction and islet loss, due to an increase in immature proinsulin granules and defects in insulin crystallization with the presence of Rod-like granules. These results correlated with the induction of autophagy, ER phagy, and crinophagy quality control mechanisms, likely to alleviate the atypical accumulation of misfolded proinsulin in the ER. In fine, BI-1 in β-cells limited IRE1α RNase activity from triggering programmed β-cell death through apoptosis and pyroptosis (caspase-1, IL-1β) via NLRP3 inflammasome activation and metabolic dysfunction. Pharmaceutical IRE1α inhibition with STF-083010 reversed β-cell failure and normalized the metabolic phenotype. These results uncover a new protective role for BI-1 in pancreatic β-cell physiology as a stress integrator to modulate the UPR triggered by accumulating unfolded proinsulin in the ER, as well as autophagy and programmed cell death, with consequences on β-cell function and insulin secretion.

RIG-I inhibits pancreatic β cell proliferation through competitive binding of activated Src

Rig-I Inhibits Pancreatic Beta Cell Proliferation Through Competitive Binding Of Activated Src

Ginsenoside Rg1 Improves Inflammation and Autophagy of the Pancreas and Spleen in Streptozotocin-Induced Type 1 Diabetic Mice.

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

Pancreatic-specific Inactivation of IGF-I Gene Causes Enlarged Pancreatic Islets and Significant Resistance to Diabetes.

Retinol-Binding Protein 4 Activates Stra6, Provoking Pancreatic Beta-Cell Dysfunction In Type 2 Diabetes

Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NF-κB/c-Myc Pathway in Pancreatic β cells

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

Toll-like receptors TLR2 and TLR4 block the replication of pancreatic β cells in diet-induced obesity

Obesity-Induced Regulator of Calcineurin 1 Overexpression Leads to Β-Cell Failure Through Mitophagy Pathway Inhibition

Retinol-Binding Protein 4 Activates STRA6 Provoking Pancreatic β Cell Dysfunction in Type 2 Diabetes

Sphingosine‑1‑phosphate Induces Islet Β‑cell Proliferation and Decreases Cell Apoptosis in High‑fat Diet/streptozotocin Diabetic Mice

Bax Inhibitor-1 preserves pancreatic β-cell proteostasis by limiting proinsulin misfolding and programmed cell death

Lipotoxicity Reduces Β Cell Survival Through Islet Stellate Cell Activation Regulated by Lipid Metabolism-Related Molecules

SH2B1 in Β-Cells Regulates Glucose Metabolism by Promoting Β-Cell Survival and Islet Expansion.

Pancreatic islet-specific overexpression of Reg3β protein induced the expression of pro-islet genes and protected the mice against streptozotocin-induced diabetes mellitus.

Sigma‐1 receptor overexpression promotes proliferation and ameliorates cell apoptosis in β‐cells

Disruption of Growth Factor Receptor–Binding Protein 10 in the Pancreas Enhances Β-Cell Proliferation and Protects Mice from Streptozotocin-Induced Β-Cell Apoptosis

Overexpression Of Foxo1 Causes Proliferation Of Cultured Pancreatic Beta Cells Exposed To Low Nutrition

Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice

Activation of SIRT1 Protects Pancreatic Β-Cells Against Palmitate-Induced Dysfunction